These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 2461007)
1. Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice. Lafon M; Bourhy H; Sureau P Vaccine; 1988 Aug; 6(4):362-8. PubMed ID: 2461007 [TBL] [Abstract][Full Text] [Related]
2. Antigenic variation in rabies and rabies-related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody. Dietzschold B; Tollis M; Rupprecht CE; Celis E; Koprowski H J Infect Dis; 1987 Nov; 156(5):815-22. PubMed ID: 3655404 [TBL] [Abstract][Full Text] [Related]
3. Vaccination challenge studies with variants of street rabies virus isolated in Nigeria. Okoh AE; Umoh JU; Ezeokoli CD; Addo PB Vaccine; 1988 Feb; 6(1):19-24. PubMed ID: 3354253 [TBL] [Abstract][Full Text] [Related]
4. Rabies virus-specific human T cell clones provide help for an in vitro antibody response against neutralizing antibody-inducing determinants of the viral glycoprotein. Bunschoten H; Klapmuts RJ; Claassen IJ; Reyneveld SD; Osterhaus AD; Uytdehaag FG J Gen Virol; 1989 Jun; 70 ( Pt 6)():1513-21. PubMed ID: 2471814 [TBL] [Abstract][Full Text] [Related]
5. Antigenic variation of wild and vaccine rabies strains of Egypt. Botros BA; Salib AW; Mellick PW; Linn JM; Soliman AK; Scott RM J Med Virol; 1988 Feb; 24(2):153-9. PubMed ID: 3351484 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to Mokola virus for identification of rabies and rabies-related viruses. Bussereau F; Vincent J; Coudrier D; Sureau P J Clin Microbiol; 1988 Dec; 26(12):2489-94. PubMed ID: 3068246 [TBL] [Abstract][Full Text] [Related]
7. The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays. Moore SM; Ricke TA; Davis RD; Briggs DJ Biologicals; 2005 Dec; 33(4):269-76. PubMed ID: 16168666 [TBL] [Abstract][Full Text] [Related]
8. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Wiktor TJ; Macfarlan RI; Reagan KJ; Dietzschold B; Curtis PJ; Wunner WH; Kieny MP; Lathe R; Lecocq JP; Mackett M Proc Natl Acad Sci U S A; 1984 Nov; 81(22):7194-8. PubMed ID: 6095272 [TBL] [Abstract][Full Text] [Related]
9. Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production. Tao L; Ge J; Wang X; Wen Z; Zhai H; Hua T; Zhao B; Kong D; Yang C; Bu Z Virol J; 2011 Sep; 8():454. PubMed ID: 21943337 [TBL] [Abstract][Full Text] [Related]
10. [Antigenic determination of human anti-rabies vaccine against viral street strains common in the wild animal population in Poland]. Seroka D Med Dosw Mikrobiol; 1994; 46(4):331-47. PubMed ID: 7541494 [TBL] [Abstract][Full Text] [Related]
12. Effect of strain differences on the potency testing of rabies vaccines in mice. Blancou J; Aubert MF; Cain E; Selve M; Thraenhart O; Bruckner L J Biol Stand; 1989 Jul; 17(3):259-66. PubMed ID: 2793877 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of rabies vaccines against Duvenhage virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related viruses. Fekadu M; Shaddock JH; Sanderlin DW; Smith JS Vaccine; 1988 Dec; 6(6):533-9. PubMed ID: 3245296 [TBL] [Abstract][Full Text] [Related]
14. Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. I. The nucleocapsid protein. Flamand A; Wiktor TJ; Koprowski H J Gen Virol; 1980 May; 48(1):97-104. PubMed ID: 6155436 [TBL] [Abstract][Full Text] [Related]
15. Rabies-specific production of interleukin-2 by peripheral blood lymphocytes from human rabies vaccinees. Perrin P; Joffret ML; Zanetti C; Bourhy H; Gontier C; Fritzell C; Leclerc C; Sureau P Vaccine; 1991 Aug; 9(8):549-58. PubMed ID: 1771968 [TBL] [Abstract][Full Text] [Related]
16. Human rabies vaccines induce neutralising antibodies against the European bat rabies virus (Duvenhage). Lafon M; Herzog M; Sureau P Lancet; 1986 Aug; 2(8505):515. PubMed ID: 2875263 [No Abstract] [Full Text] [Related]
17. [The efficacy of the ERA rabies vaccine, in mice against 4 antigenic variants of rabies virus]. Erbolato EB; da Silva EV; Miguel O; Sureau P; Germano PM Rev Saude Publica; 1989 Dec; 23(6):447-54. PubMed ID: 2641836 [TBL] [Abstract][Full Text] [Related]
18. A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge. Liu X; Yang Y; Sun Z; Chen J; Ai J; Dun C; Fu ZF; Niu X; Guo X PLoS One; 2014; 9(2):e87105. PubMed ID: 24498294 [TBL] [Abstract][Full Text] [Related]
19. Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein. Fujii H; Takita-Sonoda Y; Mifune K; Hirai K; Nishizono A; Mannen K J Gen Virol; 1994 Jun; 75 ( Pt 6)():1339-44. PubMed ID: 8207400 [TBL] [Abstract][Full Text] [Related]
20. Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection. Ray NB; Ewalt LC; Lodmell DL Vaccine; 1997 Jun; 15(8):892-5. PubMed ID: 9234541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]